Cargando…
Improved anti-tumor immunity and efficacy upon combination of the IDO1 inhibitor GDC-0919 with anti-PD-l1 blockade versus anti-PD-l1 alone in preclinical tumor models
| Autores principales: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649373/ http://dx.doi.org/10.1186/2051-1426-3-S2-P303 |
| _version_ | 1782401344276004864 |
|---|---|
| author | Spahn, Jessica Peng, Jing Lorenzana, Edward Kan, David Hunsaker, Thomas Segal, Ehud Mautino, Mario Brincks, Erik Pirzkall, Andrea Kelley, Sean Mahrus, Sami Liu, Liling Dale, Stephanie Quiason, Cristine Jones, Elizabeth Liu, Yichin Latham, Sheerin Salphati, Laurent DeMent, Kevin Merchant, Mark Hatzivassiliou, Georgia |
| author_facet | Spahn, Jessica Peng, Jing Lorenzana, Edward Kan, David Hunsaker, Thomas Segal, Ehud Mautino, Mario Brincks, Erik Pirzkall, Andrea Kelley, Sean Mahrus, Sami Liu, Liling Dale, Stephanie Quiason, Cristine Jones, Elizabeth Liu, Yichin Latham, Sheerin Salphati, Laurent DeMent, Kevin Merchant, Mark Hatzivassiliou, Georgia |
| author_sort | Spahn, Jessica |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4649373 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-46493732015-11-24 Improved anti-tumor immunity and efficacy upon combination of the IDO1 inhibitor GDC-0919 with anti-PD-l1 blockade versus anti-PD-l1 alone in preclinical tumor models Spahn, Jessica Peng, Jing Lorenzana, Edward Kan, David Hunsaker, Thomas Segal, Ehud Mautino, Mario Brincks, Erik Pirzkall, Andrea Kelley, Sean Mahrus, Sami Liu, Liling Dale, Stephanie Quiason, Cristine Jones, Elizabeth Liu, Yichin Latham, Sheerin Salphati, Laurent DeMent, Kevin Merchant, Mark Hatzivassiliou, Georgia J Immunother Cancer Poster Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4649373/ http://dx.doi.org/10.1186/2051-1426-3-S2-P303 Text en Copyright © 2015 Spahn et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation Spahn, Jessica Peng, Jing Lorenzana, Edward Kan, David Hunsaker, Thomas Segal, Ehud Mautino, Mario Brincks, Erik Pirzkall, Andrea Kelley, Sean Mahrus, Sami Liu, Liling Dale, Stephanie Quiason, Cristine Jones, Elizabeth Liu, Yichin Latham, Sheerin Salphati, Laurent DeMent, Kevin Merchant, Mark Hatzivassiliou, Georgia Improved anti-tumor immunity and efficacy upon combination of the IDO1 inhibitor GDC-0919 with anti-PD-l1 blockade versus anti-PD-l1 alone in preclinical tumor models |
| title | Improved anti-tumor immunity and efficacy upon combination of the IDO1 inhibitor GDC-0919 with anti-PD-l1 blockade versus anti-PD-l1 alone in preclinical tumor models |
| title_full | Improved anti-tumor immunity and efficacy upon combination of the IDO1 inhibitor GDC-0919 with anti-PD-l1 blockade versus anti-PD-l1 alone in preclinical tumor models |
| title_fullStr | Improved anti-tumor immunity and efficacy upon combination of the IDO1 inhibitor GDC-0919 with anti-PD-l1 blockade versus anti-PD-l1 alone in preclinical tumor models |
| title_full_unstemmed | Improved anti-tumor immunity and efficacy upon combination of the IDO1 inhibitor GDC-0919 with anti-PD-l1 blockade versus anti-PD-l1 alone in preclinical tumor models |
| title_short | Improved anti-tumor immunity and efficacy upon combination of the IDO1 inhibitor GDC-0919 with anti-PD-l1 blockade versus anti-PD-l1 alone in preclinical tumor models |
| title_sort | improved anti-tumor immunity and efficacy upon combination of the ido1 inhibitor gdc-0919 with anti-pd-l1 blockade versus anti-pd-l1 alone in preclinical tumor models |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649373/ http://dx.doi.org/10.1186/2051-1426-3-S2-P303 |
| work_keys_str_mv | AT spahnjessica improvedantitumorimmunityandefficacyuponcombinationoftheido1inhibitorgdc0919withantipdl1blockadeversusantipdl1aloneinpreclinicaltumormodels AT pengjing improvedantitumorimmunityandefficacyuponcombinationoftheido1inhibitorgdc0919withantipdl1blockadeversusantipdl1aloneinpreclinicaltumormodels AT lorenzanaedward improvedantitumorimmunityandefficacyuponcombinationoftheido1inhibitorgdc0919withantipdl1blockadeversusantipdl1aloneinpreclinicaltumormodels AT kandavid improvedantitumorimmunityandefficacyuponcombinationoftheido1inhibitorgdc0919withantipdl1blockadeversusantipdl1aloneinpreclinicaltumormodels AT hunsakerthomas improvedantitumorimmunityandefficacyuponcombinationoftheido1inhibitorgdc0919withantipdl1blockadeversusantipdl1aloneinpreclinicaltumormodels AT segalehud improvedantitumorimmunityandefficacyuponcombinationoftheido1inhibitorgdc0919withantipdl1blockadeversusantipdl1aloneinpreclinicaltumormodels AT mautinomario improvedantitumorimmunityandefficacyuponcombinationoftheido1inhibitorgdc0919withantipdl1blockadeversusantipdl1aloneinpreclinicaltumormodels AT brinckserik improvedantitumorimmunityandefficacyuponcombinationoftheido1inhibitorgdc0919withantipdl1blockadeversusantipdl1aloneinpreclinicaltumormodels AT pirzkallandrea improvedantitumorimmunityandefficacyuponcombinationoftheido1inhibitorgdc0919withantipdl1blockadeversusantipdl1aloneinpreclinicaltumormodels AT kelleysean improvedantitumorimmunityandefficacyuponcombinationoftheido1inhibitorgdc0919withantipdl1blockadeversusantipdl1aloneinpreclinicaltumormodels AT mahrussami improvedantitumorimmunityandefficacyuponcombinationoftheido1inhibitorgdc0919withantipdl1blockadeversusantipdl1aloneinpreclinicaltumormodels AT liuliling improvedantitumorimmunityandefficacyuponcombinationoftheido1inhibitorgdc0919withantipdl1blockadeversusantipdl1aloneinpreclinicaltumormodels AT dalestephanie improvedantitumorimmunityandefficacyuponcombinationoftheido1inhibitorgdc0919withantipdl1blockadeversusantipdl1aloneinpreclinicaltumormodels AT quiasoncristine improvedantitumorimmunityandefficacyuponcombinationoftheido1inhibitorgdc0919withantipdl1blockadeversusantipdl1aloneinpreclinicaltumormodels AT joneselizabeth improvedantitumorimmunityandefficacyuponcombinationoftheido1inhibitorgdc0919withantipdl1blockadeversusantipdl1aloneinpreclinicaltumormodels AT liuyichin improvedantitumorimmunityandefficacyuponcombinationoftheido1inhibitorgdc0919withantipdl1blockadeversusantipdl1aloneinpreclinicaltumormodels AT lathamsheerin improvedantitumorimmunityandefficacyuponcombinationoftheido1inhibitorgdc0919withantipdl1blockadeversusantipdl1aloneinpreclinicaltumormodels AT salphatilaurent improvedantitumorimmunityandefficacyuponcombinationoftheido1inhibitorgdc0919withantipdl1blockadeversusantipdl1aloneinpreclinicaltumormodels AT dementkevin improvedantitumorimmunityandefficacyuponcombinationoftheido1inhibitorgdc0919withantipdl1blockadeversusantipdl1aloneinpreclinicaltumormodels AT merchantmark improvedantitumorimmunityandefficacyuponcombinationoftheido1inhibitorgdc0919withantipdl1blockadeversusantipdl1aloneinpreclinicaltumormodels AT hatzivassiliougeorgia improvedantitumorimmunityandefficacyuponcombinationoftheido1inhibitorgdc0919withantipdl1blockadeversusantipdl1aloneinpreclinicaltumormodels |